Your browser doesn't support javascript.
loading
A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens.
Knikman, Jonathan E; Lopez-Yurda, Marta; Meulendijks, Didier; Deenen, Maarten J; Schellens, Jan H M; Beijnen, Jos; Cats, Annemieke; Guchelaar, Henk-Jan.
Affiliation
  • Knikman JE; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Lopez-Yurda M; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Meulendijks D; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Deenen MJ; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schellens JHM; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Beijnen J; Late Development Oncology, AstraZeneca, Cambridge, UK.
  • Cats A; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.
  • Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.
Clin Pharmacol Ther ; 115(2): 269-277, 2024 02.
Article in En | MEDLINE | ID: mdl-37957132
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fluorouracil / Neoplasms Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fluorouracil / Neoplasms Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2024 Document type: Article Affiliation country: Country of publication: